Tianfeng Securities Co., Ltd. – Corporate and Market Update
Corporate Governance On 7 November 2025 the company’s fourth board of directors convened its 57th meeting. All 12 directors participated in a written notice issued on 7 November and a subsequent electronic vote held on 26 November. The meeting, conducted in compliance with the Company Law of the People’s Republic of China and the company’s articles of association, approved the board’s agenda and passed the relevant resolution. The board affirmed that the announcement contains no false statements or omissions and that its contents are accurate and complete.
Financial Position As of 26 November 2025, Tianfeng Securities closed at CNY 4.81 per share, within a 52‑week range of CNY 3.57 to CNY 6.12. The market capitalization stands at approximately CNY 48.46 billion. The price‑earnings ratio is 78.17, indicating a valuation significantly above the sector average, reflecting market expectations of future growth.
Strategic Partnerships and Client Service In the same period, Tianfeng Securities expanded its financing services for the Hubei region. Over the past three years, the firm has facilitated nearly CNY 930 billion in financing for the broader economy and CNY 120 billion for Hubei enterprises. The company has actively engaged in bond underwriting, asset‑backed security projects, and new‑share listings on the New Third Board, collectively raising about CNY 200 billion for Hubei firms.
The company’s partnership network was reinforced by a recent signing ceremony where Tianfeng Securities entered into collaboration agreements with 22 banking institutions, including the Industrial and Commercial Bank of China, Agricultural Bank of China, and China Construction Bank, among others. These agreements aim to create a coordinated “bank‑securities‑investment” ecosystem to support high‑quality development in Hubei and the central region of China.
- Sector Outlook Tianfeng Securities’ 2026 investment strategy highlights opportunities in the petrochemical sector, particularly in the production of PX (phenyl‑acetylene) and related polymer fibers. The firm anticipates that supply‑demand imbalances, coupled with geopolitical shifts in crude oil pricing, will provide pricing elasticity for refining and downstream manufacturing.
In addition, the company’s research arm has identified significant growth potential in the medical‑aesthetic market. A recent research report emphasizes that the light‑aesthetic segment—encompassing injectables, photonic devices, fat‑reduction technologies, and service‑based models—holds considerable expansion capacity as consumer penetration increases and regulatory oversight strengthens industry health.
- Operational Focus Tianfeng Securities continues to serve customers exclusively within China, offering a comprehensive suite of services including brokerage, underwriting, consulting, asset management, credit trading, investment banking, futures, and fund businesses. The firm maintains its headquarters in Wuhan and operates under the regulatory framework of the Shanghai Stock Exchange, where it is listed as ticker 601162.
These developments collectively illustrate Tianfeng Securities’ ongoing commitment to strengthening governance, expanding its financing capabilities, and capitalizing on emerging opportunities in both the petrochemical and medical‑aesthetic sectors, while reinforcing its network of banking partners to drive economic growth in the central‑China region.
